BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 30963567)

  • 1. Inhibition of didscoidin domain receptor 1 reduces epithelial-mesenchymal transition and induce cell-cycle arrest and apoptosis in prostate cancer cell lines.
    Azizi R; Salemi Z; Fallahian F; Aghaei M
    J Cell Physiol; 2019 Nov; 234(11):19539-19552. PubMed ID: 30963567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-Regulation of DDR1 Induces Apoptosis and Inhibits EMT through Phosphorylation of Pyk2/MKK7 in DU-145 and Lncap-FGC Prostate Cancer Cell Lines.
    Azizi R; Fallahian F; Aghaei M; Salemi Z
    Anticancer Agents Med Chem; 2020; 20(8):1009-1016. PubMed ID: 32275493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin α2β1 inhibition attenuates prostate cancer cell proliferation by cell cycle arrest, promoting apoptosis and reducing epithelial-mesenchymal transition.
    Salemi Z; Azizi R; Fallahian F; Aghaei M
    J Cell Physiol; 2021 Jul; 236(7):4954-4965. PubMed ID: 33305380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition.
    Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J
    Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SRJ23, a new semisynthetic andrographolide derivative: in vitro growth inhibition and mechanisms of cell cycle arrest and apoptosis in prostate cancer cells.
    Wong HC; Wong CC; Sagineedu SR; Loke SC; Lajis NH; Stanslas J
    Cell Biol Toxicol; 2014 Oct; 30(5):269-88. PubMed ID: 25070834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-199a-5p loss up-regulated DDR1 aggravated colorectal cancer by activating epithelial-to-mesenchymal transition related signaling.
    Hu Y; Liu J; Jiang B; Chen J; Fu Z; Bai F; Jiang J; Tang Z
    Dig Dis Sci; 2014 Sep; 59(9):2163-72. PubMed ID: 24711074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. URG11 promotes proliferation and induced apoptosis of LNCaP cells.
    Sun C; Zhang G; Cheng S; Qian H; Li D; Liu M
    Int J Mol Med; 2019 May; 43(5):2075-2085. PubMed ID: 30864678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
    Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
    Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDR1 enhances invasion and metastasis of gastric cancer via epithelial-mesenchymal transition.
    Xie R; Wang X; Qi G; Wu Z; Wei R; Li P; Zhang D
    Tumour Biol; 2016 Sep; 37(9):12049-12059. PubMed ID: 27179963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of N-cadherin by Collagen I-activated Discoidin Domain Receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1.
    Huang H; Svoboda RA; Lazenby AJ; Saowapa J; Chaika N; Ding K; Wheelock MJ; Johnson KR
    J Biol Chem; 2016 Oct; 291(44):23208-23223. PubMed ID: 27605668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Anti-Proliferation, Cycle Arrest and Apoptotic Inducing Activity of Peperomin E on Prostate Cancer PC-3 Cell Line.
    Li Y; Pan J; Gou M
    Molecules; 2019 Apr; 24(8):. PubMed ID: 30991627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of discoidin domain receptor 1 (DDR1) via CpG methylation during EMT in epithelial ovarian cancer.
    Chung VY; Tan TZ; Huang RL; Lai HC; Huang RY
    Gene; 2017 Nov; 635():9-15. PubMed ID: 28887161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discoidin domain receptor 1 (DDR1), a promising biomarker, induces epithelial to mesenchymal transition in renal cancer cells.
    Song J; Chen X; Bai J; Liu Q; Li H; Xie J; Jing H; Zheng J
    Tumour Biol; 2016 Aug; 37(8):11509-21. PubMed ID: 27020590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of DDR1 Promotes Migration, Invasion, Though EMT-Related Molecule Expression and COL4A1/DDR1/MMP-2 Signaling Axis.
    Xie X; He H; Zhang N; Wang X; Rui W; Xu D; Zhu Y
    Technol Cancer Res Treat; 2020; 19():1533033820973277. PubMed ID: 33234027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cross-talk between DDR1 and STAT3 promotes the development of hepatocellular carcinoma.
    Lin Y; Jin H; Wu X; Jian Z; Zou X; Huang J; Guan R; Wei X
    Aging (Albany NY); 2020 Jul; 12(14):14391-14405. PubMed ID: 32716315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transition.
    Miao L; Zhu S; Wang Y; Li Y; Ding J; Dai J; Cai H; Zhang D; Song Y
    Med Oncol; 2013; 30(3):626. PubMed ID: 23761027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX4 induces tumor invasion by targeting EMT-related pathway in prostate cancer.
    Liu Y; Zeng S; Jiang X; Lai D; Su Z
    Tumour Biol; 2017 May; 39(5):1010428317694539. PubMed ID: 28466783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
    Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
    Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.